Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.

Autor: Zayed DG; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt., AbdElhamid AS; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta, Egypt., Freag MS; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Division of Engineering in Medicine, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Harvard-MIT Division of Health Sciences & Technology (HST), Cambridge, MA 02139, USA., Elzoghby AO; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Division of Engineering in Medicine, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Harvard-MIT Division of Health Sciences & Technology (HST), Cambridge, MA 02139, USA.
Jazyk: angličtina
Zdroj: Nanomedicine (London, England) [Nanomedicine (Lond)] 2019 Feb; Vol. 14 (3), pp. 225-228. Date of Electronic Publication: 2019 Jan 17.
DOI: 10.2217/nnm-2018-0414
Databáze: MEDLINE